320 related articles for article (PubMed ID: 33562694)
1. Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention.
Dobaño-López C; Araujo-Ayala F; Serrat N; Valero JG; Pérez-Galán P
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562694
[TBL] [Abstract][Full Text] [Related]
2. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
Hellmuth JC; Louissaint A; Szczepanowski M; Haebe S; Pastore A; Alig S; Staiger AM; Hartmann S; Kridel R; Ducar MD; Koch P; Dreyling M; Hansmann ML; Ott G; Rosenwald A; Gascoyne RD; Weinstock DM; Hiddemann W; Klapper W; Weigert O
Blood; 2018 Oct; 132(16):1695-1702. PubMed ID: 30126979
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Faria C; Gava F; Gravelle P; Valero JG; Dobaño-López C; Van Acker N; Quelen C; Jalowicki G; Morin R; Rossi C; Lagarde JM; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899130
[TBL] [Abstract][Full Text] [Related]
4. The follicular lymphoma epigenome regulates its microenvironment.
Amin R; Braza MS
J Exp Clin Cancer Res; 2022 Jan; 41(1):21. PubMed ID: 35022084
[TBL] [Abstract][Full Text] [Related]
5. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
Devan J; Janikova A; Mraz M
Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of follicular lymphoma.
Lackraj T; Goswami R; Kridel R
Best Pract Res Clin Haematol; 2018 Mar; 31(1):2-14. PubMed ID: 29452662
[TBL] [Abstract][Full Text] [Related]
7. Chromatin modifying gene mutations in follicular lymphoma.
Green MR
Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of follicular lymphoma.
Kishimoto W; Nishikori M
J Clin Exp Hematop; 2014; 54(1):23-30. PubMed ID: 24942943
[TBL] [Abstract][Full Text] [Related]
9. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
10. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
[TBL] [Abstract][Full Text] [Related]
11. Follicular lymphoma dynamics.
Milpied P; Gandhi AK; Cartron G; Pasqualucci L; Tarte K; Nadel B; Roulland S
Adv Immunol; 2021; 150():43-103. PubMed ID: 34176559
[TBL] [Abstract][Full Text] [Related]
12. T follicular helper cells: a potential therapeutic target in follicular lymphoma.
Ochando J; Braza MS
Oncotarget; 2017 Dec; 8(67):112116-112131. PubMed ID: 29340116
[TBL] [Abstract][Full Text] [Related]
13. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
14. Integrative Analysis of Cell Crosstalk within Follicular Lymphoma Cell Niche: Towards a Definition of the FL Supportive Synapse.
Pangault C; Amé-Thomas P; Rossille D; Dulong J; Caron G; Nonn C; Chatonnet F; Desmots F; Launay V; Lamy T; Fest T; Tarte K
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33028033
[TBL] [Abstract][Full Text] [Related]
15. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from gene expression profiling.
Rimsza LM; Jaramillo MC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):163-8. PubMed ID: 25696850
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of microenvironment in follicular lymphoma.
Nowakowski GS; Ansell SM
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):169-73. PubMed ID: 25696851
[TBL] [Abstract][Full Text] [Related]
17. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
[TBL] [Abstract][Full Text] [Related]
18. The tumor microenvironment in follicular lymphoma.
Yang ZZ; Ansell SM
Clin Adv Hematol Oncol; 2012 Dec; 10(12):810-8. PubMed ID: 23271353
[TBL] [Abstract][Full Text] [Related]
19. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.
Louissaint A; Schafernak KT; Geyer JT; Kovach AE; Ghandi M; Gratzinger D; Roth CG; Paxton CN; Kim S; Namgyal C; Morin R; Morgan EA; Neuberg DS; South ST; Harris MH; Hasserjian RP; Hochberg EP; Garraway LA; Harris NL; Weinstock DM
Blood; 2016 Aug; 128(8):1093-100. PubMed ID: 27325104
[TBL] [Abstract][Full Text] [Related]
20. Cancer Immunotherapy and the Immune Response in Follicular Lymphoma.
Stenner F; Renner C
Front Oncol; 2018; 8():219. PubMed ID: 29974035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]